|
NIPER Ahmedabad To Collaborate With 2
US-Based Cos Towards Development Of Medical Device Industry
Following its tie-up with Johnson & Johnson and Sahajanand
Laser Technologies for development of industry-oriented skilled manpower in the
medical device sector, the National Institute of Pharmaceutical Education and
Research (NIPER), Ahmedabad is planning to collaborate with two US-based
companies to equip the students to aggressively take up job roles for the
holistic development of domestic industry.
This would also help orient the curriculum of the post
graduate studies in medical devices run exclusively at the NIPER Ahmedabad
campus towards equipping with the latest updates on technology advancements in
the country.
This is a significant milestone as India’s import dependency
on high-end medical devices is over 80 per cent and 60 per cent to 70 per cent
for other devices. A dedicated medical devices park by the government is also
currently in the process of being set-up at Vishakhapatnam which will help in
reducing import dependency and increasing export.
Development of domestic industry has gained further impetus
as government of India is planning to expand NIPERs across the country to
nurture manpower and hence boost domestic manufacturing of medical devices in
the country. More than 70 per cent of medical devices are imported as of today
which has impacted the development of the domestic industry.
NIPER Ahmedabad had earlier this year signed two MoUs with
Johnson & Johnson and Sahajanand Laser Technologies to develop an ecosystem for
development of medical devices sector in the country.
As per official sources, a total of 17 MoUs were signed
between seven NIPERs and pharma industry for academia industry linkages
recently. Academia-industry linkage is a significant development as one of the
critical factors in building innovation ecosystem for medical devices industry.
DoP has identified that academia-industry linkage as a basic
requirement for translating research into development (commercialisation) and
innovation; and also to fix accountability among the educational institutions.
Further in India, the research and development in pharmaceuticals sector is
spread across a number of ministries and departments viz., department of
biotechnology, department of science and technology, department of scientific
and industrial research, health systems research (ICMR) and department of
pharmaceuticals.
The DoP for the last one year has actively engaged both the
NIPERs and the pharma industry to build partnership in areas of education,
research and development.
(Ref:
http://pharmabiz.com/NewsDetails.aspx?aid=97584&sid=1)
Centre To Establish 3 Mega Industrial
Parks In Gujarat For Medical Devices, Bulk Drugs
The Central government will soon establish three mega
industry parks in Gujarat which will include a Medical Devices Park, a
Pharmaceutical Formulations Park and a Bulk Drugs Park.
Speaking at the inaugural ceremony of the 7th edition of the
Pharmac India 2016 held at the Gujarat University Exhibition Hall in Ahmedabad
recently, Union minister of chemicals & fertilizers Ananth Kumar put forward a
proposal in this regard. The minister offered to develop three pharma sector
parks or clusters in Gujarat and promised funds to develop these parks in the
state.
”The Centre is ready to give all kind of support to Gujarat
if they are ready to start these parks in the state. Each park would require at
least 200 acres of land. Central government is ready provide several facilities
for these parks, such as effluent treatment plant and roads,” the Union minister
said.
Without wasting any time, the Gujarat chief minister
Vijaybhai Rupani accepted the Centre’s proposal and said his government would
start the work for identifying and acquiring the land for these parks at the
earliest. “The state government is very positive about these parks and we will do
our best to see that these parks come up at the earliest. These parks are having
a huge potential to provide employment opportunity to local youths and make
Gujarat a global pharma hub,” Rupani said.
Once in place, these mega parks will reduce the manufacturing
cost by 30 to 40 per cent, thus allowing the industry to compete with the world
and even with China.
The proposed medical devices park will be the second one in
the country similar to the Andhra Medical Technology Park, being set up in
Visakhapatnam.
The Centre has planned to develop six pharma clusters in
India, where the central government will make the investments and create
necessary infrastructure which will include testing facilities, effluent
treatment facility, etc.
(Ref:
http://www.pharmabiz.com/NewsDetails.aspx?aid=98129&sid=1)
|
